CVS Specialty improves medication adherence and access
Three new studies confirm that CVS Specialty’s pharmacist-led care model helps deliver higher adherence rates and improved outcomes.
Pharmacy
Mark Cuban Cost Plus Drug Co. expands access with addition of Starjemza
New biosimilar added to portfolio reinforces the company's commitment to transparency and access.
NCPA and Arkansas pharmacists join legal battle to preserve law barring companies from operating PBMs and pharmacies in the state
The case revolves around a state law (Act 624) passed earlier this year blocking PBMs in Arkansas from also operating pharmacies in the state.
Charitable clinics and pharmacies to receive share in $1.6 million in Equity Rx grants from Cardinal Health Foundation
Grants are a part of $5 million commitment from Cardinal Health Foundation and awarded by the National Association of Free & Charitable Clinics.
Cencora to invest $1 billion to strengthen its U.S. distribution network
The investments, including opening of a second national distribution center, support a more resilient and efficient pharmaceutical supply chain.
Danone North America to host Reddit 'Ask Me Anything' to help consumers take control of their health during American Diabetes Month
The AMA is part of a campaign to reach people with free expert information and nutrition resources to help reduce the risk of type 2 diabetes.
NACDS urges lawmakers to expand pharmacy-based care during American Pharmacists Month
Throughout American Pharmacists Month, NACDS honored pharmacists' impact and urged lawmakers to unlock pharmacy care's full potential.
Camber introduces Abacavir and Lamivudine Tablets, USP
Abacavir/Lamivudine Tablets, USP are indicated for treating HIV-1 infection.
NACDS backs Trump administration’s biosimilar action
Pharmacists ready to help Americans save more as FDA streamlines biosimilar approvals and advances interchangeability; NACDS urges Congress to finish its job on PBM reform.
Staff shortages, tariffs threaten $350B U.S. pharma investment boom
A new analysis from Global Location Strategies warns that the nation’s biopharma manufacturing boom depends on the availability of skilled labor and regulatory stability.
CVS and FARE continue Teal Pumpkin Project partnership for a safer Halloween
CVS Pharmacy continues to partner with Food Allergy Research & Education (FARE) as the exclusive pharmacy retail sponsor of the Teal Pumpkin Project.
AAM and the Biosimilars Council praise FDA announcement on biosimilars clinical efficacy studies and interchangeability
FDA Commissioner Makary joined AAM’s GRx+Biosims 2025 conference today.
FDA aims to speed up biosimilar development and lower drug costs
In a new draft guidance, the FDA proposes major updates to simplify biosimilarity studies and reduce unnecessary clinical testing.
Lilly to invest over $1.2 billion to expand Puerto Rico facility
The enhanced facility will be among those that will manufacture for orforglipron, Lilly’s first oral, small-molecule GLP-1 receptor agonist.
SHARx unshackles U.S. Rx delivery system
SHARx operates on a transparent pricing model—charging a simple subscription fee.